UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood

Circulation research, 2003-11, Vol.93 (11), p.1023-1025

2003

Volltextzugriff (PDF)

Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues

Science translational medicine, 2018-01, Vol.10 (425)

2018

Volltextzugriff (PDF)

Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity

Gene therapy, 2009-05, Vol.16 (5), p.689-699

2009

Volltextzugriff (PDF)

Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin–paclitaxel doublet chemotherapy

Gene therapy, 2013-05, Vol.20 (5), p.521-528

2013

Volltextzugriff (PDF)

Effective Targeting of Solid Tumors in Patients With Locally Advanced Cancers by Radiolabeled Pegylated Liposomes

Clinical cancer research, 2001-02, Vol.7 (2), p.243-254

2001

Volltextzugriff (PDF)

Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling

Gene therapy, 2012-05, Vol.19 (5), p.543-549

2012

Volltextzugriff (PDF)

Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells

Nature medicine, 2005-10, Vol.11 (10), p.1073-1081

2005

Volltextzugriff (PDF)

Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors

Gene therapy, 2008-04, Vol.15 (8), p.604-616

2008

Volltextzugriff (PDF)

Autologous culture-modified mononuclear cells confer vascular protection after arterial injury

Circulation (New York, N.Y.), 2003-09, Vol.108 (12), p.1520-1526

2003

Volltextzugriff (PDF)

Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

Nature medicine, 1998-05, Vol.4 (5), p.581-587

1998

Volltextzugriff (PDF)

Heat Shock Protein 70 Induced During Tumor Cell Killing Induces Th1 Cytokines and Targets Immature Dendritic Cell Precursors to Enhance Antigen Uptake

The Journal of immunology (1950), 1999-08, Vol.163 (3), p.1398-1408

1999

Volltextzugriff (PDF)

Phase I-II study of pegylated liposomal cisplatin (SPI-077 TM) in patients with inoperable head and neck cancer

Annals of oncology, 2001-04, Vol.12 (4), p.493-496

2001

Volltextzugriff (PDF)

Cancer gene therapy : hard lessons and new courses

Gene therapy, 2000, Vol.7 (1), p.2-8

2000

Volltextzugriff (PDF)

A simple method to cure established tumors by inflammatory killing of normal cells

Nature biotechnology, 2004-09, Vol.22 (9), p.1125-1132

2004

Volltextzugriff (PDF)

Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (5), p.2009-2017

2005

Volltextzugriff (PDF)

MIP-3α Transfection into a Rodent Tumor Cell Line Increases Intratumoral Dendritic Cell Infiltration but Enhances (Facilitates) Tumor Growth and Decreases Immunogenicity

The Journal of immunology (1950), 2004-10, Vol.173 (8), p.4929-4935

2004

Volltextzugriff (PDF)

Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth

Cancer research (Chicago, Ill.), 2000-03, Vol.60 (6), p.1492-1497

2000

Volltextzugriff (PDF)

Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor

Gene therapy, 2010-08, Vol.17 (8), p.1000-1010

2010

Volltextzugriff (PDF)

Intratumoral immunotherapy: using the tumour against itself

Immunology, 2005-01, Vol.114 (1), p.11-22

2005

Volltextzugriff (PDF)

Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity

Cancer research (Chicago, Ill.), 2003-09, Vol.63 (17), p.5505-5512

2003

Volltextzugriff (PDF)

Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells

Cancer research (Chicago, Ill.), 2002-11, Vol.62 (22), p.6566-6578

2002

Volltextzugriff (PDF)

Generation of an anti‐tumour immune response in a non‐immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1‐like profile of intratumoural cytokine expression

International journal of cancer, 1997-04, Vol.71 (2), p.267-274

1997

Volltextzugriff (PDF)

Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component

Cancer research (Chicago, Ill.), 1994-12, Vol.54 (23), p.6228-6234

1994

Volltextzugriff (PDF)

Induction of Human T Lymphocyte Cytotoxicity and Inhibition of Tumor Growth by Tumor-Specific Diabody-Based Molecules Secreted from Gene-Modified Bystander Cells

The Journal of immunology (1950), 2003-07, Vol.171 (2), p.1070-1077

2003

Volltextzugriff (PDF)

Modulation of the vascular response to injury by autologous blood-derived outgrowth endothelial cells

American journal of physiology. Heart and circulatory physiology, 2004-08, Vol.287 (2), p.H512-H517

2004

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(87)

Sprache

Englisch
(87)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood

Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues

Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity

Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin–paclitaxel doublet chemotherapy

Effective Targeting of Solid Tumors in Patients With Locally Advanced Cancers by Radiolabeled Pegylated Liposomes

Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling

Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells

Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumors

Autologous culture-modified mononuclear cells confer vascular protection after arterial injury

Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

Heat Shock Protein 70 Induced During Tumor Cell Killing Induces Th1 Cytokines and Targets Immature Dendritic Cell Precursors to Enhance Antigen Uptake

Phase I-II study of pegylated liposomal cisplatin (SPI-077 TM) in patients with inoperable head and neck cancer

Cancer gene therapy : hard lessons and new courses

A simple method to cure established tumors by inflammatory killing of normal cells

Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo

MIP-3α Transfection into a Rodent Tumor Cell Line Increases Intratumoral Dendritic Cell Infiltration but Enhances (Facilitates) Tumor Growth and Decreases Immunogenicity

Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth

Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor

Intratumoral immunotherapy: using the tumour against itself

Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity

Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells

Generation of an anti‐tumour immune response in a non‐immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1‐like profile of intratumoural cytokine expression

Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component

Induction of Human T Lymphocyte Cytotoxicity and Inhibition of Tumor Growth by Tumor-Specific Diabody-Based Molecules Secreted from Gene-Modified Bystander Cells

Modulation of the vascular response to injury by autologous blood-derived outgrowth endothelial cells

Suchergebnisse filtern